Transvaginal Mesh

Transvaginal Mesh Market Outlook

The global transvaginal mesh market is projected to reach approximately USD 1.1 billion by 2035, growing at a compound annual growth rate (CAGR) of about 5.8% during the forecast period from 2025 to 2035. This growth is significantly driven by the increasing prevalence of pelvic organ prolapse (POP) and stress urinary incontinence (SUI), leading to a rising demand for effective and minimally invasive surgical solutions. Furthermore, advancements in surgical techniques, coupled with a growing awareness among patients regarding treatment options, are expected to fuel market growth. The increasing geriatric population, especially in developed regions, is also contributing to the demand for transvaginal mesh products. Additionally, ongoing research and development activities aimed at improving the efficacy and safety of mesh materials are anticipated to enhance market opportunities and growth.

Growth Factor of the Market

The transvaginal mesh market is primarily driven by a growing recognition of the necessity for efficient surgical interventions for conditions such as pelvic organ prolapse and urinary incontinence. The increasing number of surgical procedures performed globally, along with the rising awareness among healthcare professionals about the effectiveness of transvaginal mesh in providing better surgical outcomes, is fostering market growth. The shift towards minimally invasive surgical techniques is another significant factor contributing to the market's expansion, as these techniques often result in reduced recovery times and lower complication rates for patients. In addition, the enhanced focus on women's health and the proactive measures taken by various healthcare organizations to improve treatment options are expected to further boost market demand. Lastly, the continuous advancements in mesh technology, including the development of bio-compatible and absorbable materials, are creating new opportunities in this sector.

Key Highlights of the Market

• The market is projected to grow at a CAGR of 5.8% from 2025 to 2035.
• North America is anticipated to hold the largest market share, driven by advanced healthcare infrastructure.
• The rising prevalence of pelvic organ prolapse and urinary incontinence conditions is significantly fueling market demand.
• Technological advancements in surgical devices are enhancing the outcomes of mesh surgeries.
• Increased patient awareness regarding women's health issues is contributing to market growth.

By Product Type

Synthetic Mesh:

Synthetic mesh is one of the most commonly used types of transvaginal mesh due to its strength and durability. Composed mainly of materials like polypropylene, it offers high tensile strength, allowing for effective support during surgical procedures for conditions such as pelvic organ prolapse and stress urinary incontinence. The widespread use of synthetic mesh is further driven by its cost-effectiveness compared to biological alternatives. However, the potential for complications related to synthetic materials, including erosion and infection, has raised concerns among healthcare providers and patients alike. This has prompted ongoing research into improving the biocompatibility of synthetic meshes to minimize adverse effects while still providing effective support for surgical repairs.

Biological Mesh:

Biological mesh, typically derived from animal tissues, offers a natural alternative for patients requiring transvaginal mesh procedures. Its key advantage lies in its biocompatibility, which significantly reduces the risk of rejection or complications associated with synthetic materials. This type of mesh is particularly favored in patients with a history of mesh-related complications or those who prefer biological solutions. However, the higher cost and limited availability of biological mesh remain challenges in its widespread adoption. Furthermore, the longevity and durability of biological meshes compared to synthetic options are still under evaluation, making it crucial for ongoing clinical studies to assess their long-term effectiveness in various applications.

Composite Mesh:

Composite mesh combines both synthetic and biological materials, aiming to leverage the benefits of each type while minimizing their limitations. The synthetic component provides the necessary structural support, while the biological element promotes tissue integration and reduces the risk of complications. This innovative approach allows for enhanced performance in surgical repairs, making composite mesh an attractive option for both surgeons and patients. Though composite meshes are gaining traction in the market, their relatively higher costs and the need for further clinical validation regarding their efficacy in long-term applications present challenges for broader acceptance and use in practices.

Absorbable Mesh:

Absorbable mesh has emerged as an alternative option in the transvaginal mesh market, designed to gradually dissolve in the body over time following surgery. This type of mesh is particularly beneficial for patients who may be at risk for long-term complications associated with permanent meshes. The key advantage of absorbable mesh lies in its ability to provide temporary support for healing tissues while minimizing the risk of erosion or chronic pain. However, the complexity of surgical procedures and variability in individual healing processes may limit its widespread application. Further research is required to establish the optimal scenarios for using absorbable mesh and to validate its long-term performance compared to traditional options.

Non-absorbable Mesh:

Non-absorbable mesh is designed to remain permanently in the body post-surgery, providing continuous support for pelvic structures. This type of mesh is often preferred in cases of severe pelvic organ prolapse or chronic urinary incontinence, where a durable solution is required. Non-absorbable mesh offers significant advantages in terms of long-term support and stability; however, it also carries the potential risks of complications, such as mesh erosion and chronic pain. The growing demand for minimally invasive procedures has led to innovations aimed at improving the safety profiles of non-absorbable meshes, making them a key focus area for manufacturers and researchers in the field of gynecological surgery.

By Application

Pelvic Organ Prolapse Repair:

The application of transvaginal mesh for pelvic organ prolapse repair is one of the primary drivers of market growth. Pelvic organ prolapse is a prevalent condition, particularly among women who have undergone childbirth or are in the post-menopausal stage. Treatment using transvaginal mesh provides a minimally invasive solution that can effectively restore pelvic support and alleviate symptoms associated with prolapse. The growing awareness and acceptance of mesh procedures among patients and healthcare providers have also contributed to the increased adoption of this treatment option. As new guidelines and best practices continue to emerge, surgical techniques are becoming more refined, thus enhancing the efficacy and safety of pelvic organ prolapse repairs using transvaginal mesh.

Stress Urinary Incontinence:

Stress urinary incontinence is another significant application area for transvaginal mesh, as it affects a considerable proportion of the female population. The use of mesh in surgical interventions, such as mid-urethral sling procedures, provides effective support to the urethra and bladder, significantly improving patient quality of life. The increasing prevalence of stress urinary incontinence, particularly among aging populations, is driving demand for surgical interventions incorporating transvaginal mesh. Additionally, advancements in surgical techniques and the development of specialized mesh products designed explicitly for this application are expected to enhance outcomes and broaden the acceptance of these procedures in clinical practice.

Hernia Repair:

Transvaginal mesh is also utilized in hernia repair procedures, where its ability to provide durable support and promote tissue integration is highly valued. The versatility of transvaginal mesh applications has positioned it as a key player in addressing various types of hernias, particularly in women who may have concurrent pelvic floor disorders. The demand for effective hernia repair solutions is growing due to an increase in surgery rates and a heightened focus on minimally invasive techniques. Manufacturers are developing innovative mesh products tailored for hernia repair, which is expected to stimulate market growth further. As more clinicians recognize the advantages of utilizing transvaginal mesh for hernia repair, this application segment is likely to see significant expansion in the coming years.

By Distribution Channel

Hospitals:

Hospitals remain the primary distribution channel for transvaginal mesh products, as they are where a majority of surgical procedures are conducted. The extensive infrastructure, specialized surgical teams, and advanced technology available in hospitals contribute to their dominance in the market. Additionally, hospitals often have established relationships with manufacturers and distributors, allowing them to access the latest products and innovations efficiently. The increasing number of surgical procedures performed in hospitals, driven by the rising prevalence of pelvic organ prolapse and urinary incontinence, further solidifies this channel's importance in the overall market dynamics.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are emerging as a significant distribution channel for transvaginal mesh, offering a cost-effective alternative to traditional hospital settings. These centers provide outpatient surgical services, allowing patients to undergo procedures and return home on the same day. The growing preference for outpatient surgery is fueling the demand for transvaginal mesh in ASCs, as they often focus on minimally invasive techniques that align with patient-centered care approaches. Additionally, the increasing number of procedures being performed in ASCs is expected to propel this channel's growth, as patients and providers alike seek efficient and convenient surgical options.

Specialty Clinics:

Specialty clinics play a crucial role in the distribution of transvaginal mesh products, particularly those focused on women's health and pelvic floor disorders. These clinics offer specialized care and expertise in managing conditions such as pelvic organ prolapse and urinary incontinence, leading to better patient outcomes. The personalized approach and tailored treatment plans provided by specialty clinics contribute to their growing significance in the market. As awareness of pelvic health issues continues to rise, these clinics are well-positioned to capture a larger share of the transvaginal mesh market, offering innovative solutions and advanced surgical techniques.

Online Sales:

Online sales channels are gradually gaining traction in the transvaginal mesh market, driven by the increasing digitalization of healthcare and patient preferences for convenience. Patients and providers can access product information, reviews, and comparisons through online platforms, facilitating informed decision-making. The ease of ordering and the ability to access a wide range of products online are appealing to both practitioners and patients. However, the online sales channel faces challenges related to product authenticity, regulatory compliance, and the need for professional consultations. As e-commerce continues to evolve within the healthcare sector, online sales of transvaginal mesh products are likely to expand, provided that measures are taken to ensure quality and safety standards.

By Material Type

Polypropylene:

Polypropylene is one of the most widely used materials in the production of transvaginal mesh, offering excellent tensile strength and durability. This synthetic polymer is favored for its cost-effectiveness and ability to provide long-lasting support during surgical procedures. Polypropylene mesh is designed to integrate with surrounding tissues, enhancing its effectiveness in treating conditions such as pelvic organ prolapse and urinary incontinence. However, despite its advantages, there are concerns about the potential for complications related to polypropylene mesh, such as erosion and chronic pain. Ongoing research and innovation in polypropylene formulations aim to improve biocompatibility and reduce adverse effects associated with this material.

Polyester:

Polyester is another material used in the manufacturing of transvaginal mesh, primarily known for its flexibility and adaptability in surgical applications. This material provides good strength and can be woven into various configurations to meet specific surgical needs. While polyester mesh offers advantages in terms of ease of handling and implantation, there are concerns regarding its long-term effectiveness compared to polypropylene. Studies have shown that polyester mesh may have a higher risk of infection and other complications, leading to a more cautious approach in its use. As the focus on patient safety continues to grow, the development of optimized polyester mesh products is crucial for enhancing their acceptance and performance in clinical settings.

Polytetrafluoroethylene:

Polytetrafluoroethylene (PTFE) is a specialized material utilized in some transvaginal mesh products, known for its remarkable biocompatibility and low friction properties. PTFE mesh is designed to minimize tissue adhesion and irritation, making it suitable for patients with a history of complications related to other mesh materials. The unique properties of PTFE contribute to its effectiveness in various surgical applications, particularly in cases where reduced tissue reaction is desired. However, the higher cost of PTFE materials and the need for further clinical validation regarding their long-term performance present challenges to its widespread adoption. As research continues to explore the potential of PTFE mesh, it may gain traction as a viable alternative in the transvaginal mesh market.

Polyethylene:

Polyethylene is a less common material used in the production of transvaginal mesh but offers unique properties that may benefit specific applications. This polymer is known for its lightweight characteristics and flexibility, making it suitable for minimally invasive surgical procedures. However, the use of polyethylene mesh is limited due to concerns regarding its long-term stability and potential for complications. Ongoing research is focused on enhancing the properties of polyethylene to improve its suitability for transvaginal mesh applications. As material science progresses, innovative polyethylene formulations may emerge, addressing current limitations and expanding its use in the market.

By Region

The North American region holds the largest share of the transvaginal mesh market, accounting for approximately 45% of the total market value. The prevalence of pelvic organ prolapse and urinary incontinence, coupled with advanced healthcare infrastructure, drives demand for transvaginal mesh in this region. The increasing number of surgical procedures, along with a growing focus on women's health, further contributes to the region's market growth. Furthermore, North America is characterized by a high level of awareness among healthcare providers and patients regarding available treatment options, which stimulates adoption rates of transvaginal mesh products. This region is projected to maintain its dominance throughout the forecast period, with a CAGR of around 5.5% from 2025 to 2035.

Europe is the second-largest market for transvaginal mesh, accounting for approximately 30% of the global market share. The region benefits from a well-established healthcare system and increasing investments in women's health initiatives. The rising prevalence of pelvic floor disorders, coupled with the growing acceptance of surgical interventions among patients, is propelling market growth in Europe. However, varying regulatory standards and guidelines surrounding the use of transvaginal mesh products in different countries may pose challenges to market expansion. Asia Pacific is also emerging as a significant market, with an anticipated CAGR of 6.2% during the forecast period, driven by increasing healthcare access, rising awareness of women's health issues, and a growing geriatric population.

Opportunities

The transvaginal mesh market presents numerous opportunities for growth, particularly in emerging markets where access to healthcare is improving. As countries invest in healthcare infrastructure and prioritize women's health issues, the demand for effective surgical solutions is expected to rise. The increasing prevalence of pelvic organ prolapse and urinary incontinence in aging populations is anticipated to create a substantial market for transvaginal mesh products. Furthermore, manufacturers are likely to focus on research and development to introduce innovative products with improved safety profiles and reduced complication rates. Collaborations with healthcare providers and educational initiatives aimed at increasing awareness of treatment options are also crucial in expanding market reach and enhancing acceptance of transvaginal mesh solutions.

Additionally, as the healthcare landscape evolves, there is potential for growth in the online sales channel, providing patients with greater accessibility to products and information. The increasing trend of telehealth and remote consultations can further elevate the demand for transvaginal mesh as patients seek effective treatment options from the comfort of their homes. Moreover, as the focus on personalized medicine and patient-centered care continues to gain momentum, opportunities for tailored solutions that meet individual patient needs are likely to emerge. Manufacturers that prioritize innovation and adapt to changing market dynamics will be well-positioned to capitalize on these opportunities and drive market growth over the coming years.

Threats

The transvaginal mesh market faces several threats that could impact its growth trajectory. One of the primary concerns is the increasing scrutiny and regulatory challenges surrounding the use of mesh products. High-profile lawsuits and reports of complications associated with transvaginal mesh have led to heightened regulatory oversight and calls for stricter guidelines. Such scrutiny can deter healthcare providers from adopting or recommending mesh procedures, resulting in a decline in demand. Additionally, the emergence of alternative treatment options, such as pelvic floor exercises and minimally invasive non-surgical interventions, can pose threats to the market, particularly among patients seeking less invasive solutions. Furthermore, public perception and media coverage of mesh-related complications can lead to mistrust among patients and healthcare providers, potentially stalling market growth.

Another significant concern is the potential for adverse effects and complications related to transvaginal mesh. The risk of mesh erosion, infection, and chronic pain can result in negative patient experiences and dissatisfaction, which may lead to increased litigation and public backlash. Manufacturers face the challenge of addressing these concerns by investing in research to develop safer, more effective products. The need for ongoing education and training for healthcare providers is crucial to ensuring proper implantation techniques and minimizing complications. Any failure to address these threats could hinder the overall acceptance and market growth of transvaginal mesh products.

Competitor Outlook

• Boston Scientific Corporation
• Johnson & Johnson
• Medtronic
• Synthes GmbH
• Coloplast A/S
• Cook Medical
• Hernia Solutions
• Terumo Corporation
• Bard Medical Division
• Ethicon, Inc.
• Neomedic International
• UroMed, LLC
• Endo International plc
• American Medical Systems
• Advantum Health

The competitive landscape of the transvaginal mesh market is characterized by a diverse array of players, ranging from large multinational corporations to specialized manufacturers focused on women's health. Leading companies such as Boston Scientific, Johnson & Johnson, and Medtronic dominate the market, leveraging their extensive resources and established product lines to maintain a competitive edge. These companies invest heavily in research and development to innovate and improve their transvaginal mesh products, thereby enhancing safety profiles and clinical outcomes. Partnerships and collaborations between industry leaders and academic institutions are increasingly common as companies seek to advance their technologies and address patient safety concerns effectively.

In addition to established players, several emerging companies are making their mark in the transvaginal mesh market by focusing on niche applications and developing innovative products. The presence of specialized manufacturers, such as Neomedic International and UroMed, allows for tailored solutions that cater to specific patient needs and preferences. These companies often prioritize patient education and awareness, recognizing the importance of informing patients about their treatment options and potential risks associated with transvaginal mesh. As the market continues to evolve, the competition is expected to intensify, prompting both established and emerging players to differentiate themselves through product innovation, enhanced safety measures, and improved patient outcomes.

Several key players in the transvaginal mesh market have established themselves as leaders in product innovation and safety. For instance, Boston Scientific Corporation has developed an extensive range of mesh products specifically designed for pelvic floor reconstruction, focusing on minimizing complication rates through advanced materials and designs. The company's commitment to research and development has led to the introduction of newer mesh technologies that enhance patient outcomes while addressing safety concerns. Similarly, Johnson & Johnson's Ethicon division has gained recognition for its innovative mesh solutions, which are backed by ongoing clinical studies aimed at validating their long-term effectiveness.

Medtronic, another significant player in the market, has leveraged its extensive experience in medical devices to offer a range of transvaginal mesh products for various applications. The company places a strong emphasis on patient safety and satisfaction, continually updating its product lines based on feedback from healthcare providers and patients. The strategic focus on innovation, patient education, and collaborations with healthcare professionals enables Medtronic to maintain a competitive advantage in the rapidly evolving transvaginal mesh market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Medtronic
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 UroMed, LLC
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Cook Medical
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Synthes GmbH
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Coloplast A/S
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Ethicon, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Advantum Health
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Hernia Solutions
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Johnson & Johnson
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Terumo Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Bard Medical Division
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Endo International plc
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Neomedic International
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 American Medical Systems
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Boston Scientific Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Transvaginal Mesh Market, By Application
    • 6.1.1 Pelvic Organ Prolapse Repair
    • 6.1.2 Stress Urinary Incontinence
    • 6.1.3 Hernia Repair
  • 6.2 Transvaginal Mesh Market, By Product Type
    • 6.2.1 Synthetic Mesh
    • 6.2.2 Biological Mesh
    • 6.2.3 Composite Mesh
    • 6.2.4 Absorbable Mesh
    • 6.2.5 Non-absorbable Mesh
  • 6.3 Transvaginal Mesh Market, By Material Type
    • 6.3.1 Polypropylene
    • 6.3.2 Polyester
    • 6.3.3 Polytetrafluoroethylene
    • 6.3.4 Polyethylene
  • 6.4 Transvaginal Mesh Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Ambulatory Surgical Centers
    • 6.4.3 Specialty Clinics
    • 6.4.4 Online Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Transvaginal Mesh Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Transvaginal Mesh market is categorized based on

By Product Type

• Synthetic Mesh
• Biological Mesh
• Composite Mesh
• Absorbable Mesh
• Non-absorbable Mesh

By Application

• Pelvic Organ Prolapse Repair
• Stress Urinary Incontinence
• Hernia Repair

By Distribution Channel

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Online Sales

By Material Type

• Polypropylene
• Polyester
• Polytetrafluoroethylene
• Polyethylene

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Boston Scientific Corporation
• Johnson & Johnson
• Medtronic
• Synthes GmbH
• Coloplast A/S
• Cook Medical
• Hernia Solutions
• Terumo Corporation
• Bard Medical Division
• Ethicon, Inc.
• Neomedic International
• UroMed, LLC
• Endo International plc
• American Medical Systems
• Advantum Health